New market for liver disease spawns race for better testing

March 15, 2015 12:32 PM

5 0

New market for liver disease spawns race for better testing

NEW YORK (Reuters) - As drugmakers develop new medicines to battle a liver disease epidemic, they have created an urgent need for better diagnostics to select patients for treatment and assess their drugs' effectiveness.

About 30 percent of people in the U.S. now suffer from fatty liver diseases, such as NASH (nonalcoholic steatohepatitis), fueled by obesity, diabetes and over-indulgent lifestyles, according to the American Liver Foundation. Without treatment, sufferers can develop advanced damage, including the sca...

Also read: RBS Fails Toughest-Ever BOE Stress Test, Boosts Capital Plan

Read more

To category page

Loading...